Viewing nowCombinationWidian Duo Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202201371 · Approved 2022.04.04 · Insurance code 660703940
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in controlling blood sugar in adults with type 2 diabetes by combining Empagliflozin and Metformin. It is administered as an adjunct therapy to patients who are also engaging in diet and exercise. In patients with type 2 diabetes who do not have adequate blood sugar control, particularly those with cardiovascular disease, expert guidance is required regarding the impact of this medication on the occurrence of cardiovascular events. Therefore, it is important to consult with a doctor before taking this medication to receive appropriate guidance. This medication effectively helps improve blood sugar levels.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were previously taking. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient medicines. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used to treat diabetes and helps lower blood sugar levels. It may cause a rare side effect known as severe lactic acidosis; therefore, patients with poor kidney function or issues with the heart or liver should not use it. Additionally, caution is necessary as hypoglycemia may occur when taken with insulin or other diabetes medications. Patients with reduced kidney function, acute infections, dehydration, severe injuries, or those scheduled for surgery should temporarily discontinue this medication. It is also safer for pregnant or breastfeeding women not to take this medication. This medication may lead to side effects such as urinary tract infections or genital infections, increased urination, and there is a risk of low blood pressure due to fluid loss. While taking the medication, regular blood tests should be conducted to monitor kidney function and vitamin B12 levels, and it is advisable to avoid alcohol consumption. If symptoms such as vomiting, diarrhea, abdominal pain, shortness of breath, muscle pain, or lethargy occur, medical personnel should be notified immediately. Patients taking this medication should be alert to symptoms of hypoglycemia, and if such symptoms manifest, appropriate measures are needed. Furthermore, this medication should be stopped before and after tests involving certain contrast agents and can be resumed after kidney function returns to normal. Elderly patients should be cautious due to the risk of decreased kidney function, requiring dose adjustments and regular monitoring. Emergency treatment is necessary in case of overdose, especially for lactic acidosis, which requires immediate medical attention. This medication is not recommended for children, and while no special effects have been reported while driving or operating machinery, caution is still advised. Finally, this medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and prevent degradation.
Brownish yellow, oval-shaped, biconvex film-coated tablet
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.